Open AccessP034 Assessment of age as a risk factor for adverse events in patients from the tofacitinib ulcerative colitis clinical program
Author(s) -
Gary R. Lichtenstein,
Brian Bressler,
Gary Chan,
Chinyu Su,
Friedman Gary,
Nervin Lawendy,
Ronald Pedersen,
Leonardo Salese,
Edward V. Loftus
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000578208.09449.08
Subject(s) - tofacitinib , medicine , ulcerative colitis , cohort , adverse effect , placebo , cohort study , janus kinase inhibitor , surgery , rheumatoid arthritis , pathology , disease , alternative medicine